Journal of Substance Abuse Treatment

Papers
(The H4-Index of Journal of Substance Abuse Treatment is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
C2: editorial board113
JSAT call for papers for special issue: Stimulant use disorder98
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study83
Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids80
Substance use disorders among older populations: What role do race and ethnicity play in treatment and completion?68
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail59
Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings53
Augmenting substance use treatment in the drug court: A pilot randomized trial of peer recovery support53
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder49
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up48
Integrating substance use care into primary care for adolescents and young adults: Lessons learned47
A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts47
Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care45
Clinical symptoms and personality traits predict subpopulations of treatment-seeking substance users44
C2: editorial board42
The new services that opioid treatment programs have adopted in response to COVID-1940
Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders40
Views of barriers and facilitators to continuing methadone treatment upon release from jail among people receiving patient navigation services39
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data39
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail39
Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: A qualitative analysis38
C2: editorial board37
Serial mediation analysis of treatment-specific processes in two contrasting alcohol treatments37
Education and careers were our way out36
Use of non–prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration32
Al-Anon Intensive Referral (AIR): A qualitative formative evaluation for implementation32
Suicide safer care in behavioral health settings: A comparative analysis of perceptions, training completion, and practice between mental health and substance use disorder treatment providers31
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings30
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)30
What is the relapse risk during treatment? Survivor analysis of single and multiple relapse events in inpatients with alcohol use disorder as part of an observational study30
0.1933331489563